Veradermics (MANE), a small biotechnology company looking to develop drugs for hair loss,…
Source: [https://www.barrons.com/articles/veradermics-ipo-stock-price-bf5ed7e8](https://www.barrons.com/articles/veradermics-ipo-stock-price-bf5ed7e8)...
Veradermics completes enrollment in second Phase 3 trial for oral hair-loss drug
Veradermics has finished enrollment in its second pivotal Phase 3 trial of VDPHL01, results expected for 1H 2026!!!! source: [https://ir.veradermics.com/news-releases/news-release-details/veradermics...
Veradermics concludes enrolment in second Phase III VDPHL01 trial
Veradermics completed enrolment for both Phase III VDPHL01 trials in male pattern hair loss, totalling over 1,000 participants.
Veradermics + 47 hair/cm2 in only 4 months
This is the press release of the clinical trial phase 2. They have finished to enroll for the phase 3. Seems good news. [https://www.veradermics.com/veradermics-completes-phase2-3-enrollment/](https:/...
Veradermics Completes Enrollment in its Phase 2/3 Clinical Trial of ...
Dec 11, 2025 · Veradermics’ lead program, VDPHL01, is an extended-release oral minoxidil tablet in Phase 3 development for the treatment of pattern hair loss — the largest aesthetics condition …
Veradermics Raises $75 Million in Series B Financing and Initiates ...
Dec 11, 2024 · NEW HAVEN, Conn.– (BUSINESS WIRE)–Veradermics, a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for …
Contact Us | Veradermics
Veradermics is on a mission to make long-ignored dermatology and aesthetics conditions simple — replacing false hope, confusion, and questionable results with solutions that people and providers …
Veradermics Announces Oversubscribed $150 Million Series C …
Oct 16, 2025 · Veradermics’ lead program, VDPHL01, is an extended-release oral minoxidil tablet in Phase 3 development for the treatment of pattern hair loss — the largest aesthetics condition …
Our Approach | Veradermics
Veradermics aims to change this. We’re a new style of pharmaceutical company: driven by purpose, powered by science, and committed to bold therapeutic progress. Our differentiated pipeline is …
About Us | Veradermics
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
Investor Relations | Veradermics, Inc.
4 days ago · Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
Our Pipeline | Veradermics
Veradermics is advancing a robust pipeline of product candidates with first-in-class aesthetic and dermatological solutions. Learn more.
Dermatology and Aesthetics Solutions | Veradermics
Feb 9, 2026 · Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
Veradermics Completes Enrollment in its Phase 2/3 Clinical Trial of ...
Dec 11, 2025 · Veradermics’ lead program, VDPHL01, is an extended-release oral minoxidil tablet in Phase 3 development for the treatment of pattern hair loss — the largest aesthetics condition …
Veradermics Raises $75 Million in Series B Financing and Initiates ...
Dec 11, 2024 · NEW HAVEN, Conn.– (BUSINESS WIRE)–Veradermics, a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for …
Contact Us | Veradermics
Veradermics is on a mission to make long-ignored dermatology and aesthetics conditions simple — replacing false hope, confusion, and questionable results with solutions that people and providers …
Veradermics Announces Oversubscribed $150 Million Series C …
Oct 16, 2025 · Veradermics’ lead program, VDPHL01, is an extended-release oral minoxidil tablet in Phase 3 development for the treatment of pattern hair loss — the largest aesthetics condition …
Our Approach | Veradermics
Veradermics aims to change this. We’re a new style of pharmaceutical company: driven by purpose, powered by science, and committed to bold therapeutic progress. Our differentiated pipeline is …
About Us | Veradermics
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
Investor Relations | Veradermics, Inc.
4 days ago · Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.